Breast

A study suggests the drugs used to initially treat breast cancer may be triggering some cancer cells to enter a dormant state.

New research from the University of Virginia suggests an unhealthy gut microbiome can actively promote the spread of breast cancer. Through a series of animal experiments the new study demonstrated how disruptions to gut bacterial populations can drive metastatic spread of tumor cells.

Researchers in Vienna are making some promising progress in the field of breast cancer detection, developing a new method that revolves around a waistcoat packed with flexible radio frequency coils.

A new online tool has been developed that allows GPs to effectively calculate a patient's risk of developing breast cancer. The system is the first to combine a broad array of different elements, including genetics and environmental factors, to come up with a precise risk evaluation.

Scientists have discovered a protein than can predict whether a patient’s metastasized breast cancer is dormant or about to turn deadly. The research points to new treatments that may be able to stimulate dormancy in cancer cells before they metastasize.​

Promising early results are in from a phase 1 clinical trial into a new cancer vaccine designed to stimulate the immune system into attacking certain cancers known to overexpress a specific protein.

​For nursing mothers who don't wish to be tied down to a non-portable breast pump, there are already wearable versions that can be slipped under a bra. Women's tech company Elvie is taking things a step further, by announcing what it claims is the world's first silent wearable breast pump.

Finding ways to stop metastasis is a key way to improve survival rates for cancer patients. Now researchers have found that primary tumors have their own mechanism for slowing the growth of secondary cancers – which could be tapped into as a new potential treatment option.

A case study from an ongoing clinical trial has revealed an experimental immunotherapy treatment has cured a breast cancer patient. The patient, with advanced breast cancer, was given three months to live before enrolling into the trial. Within weeks her tumors had disappeared.

Mammograms can miss harmful but treatable cancers, while other patients with benign tumors undergo unnecessary invasive procedures. Now scientists have developed a new diagnostic tool that’s much easier to swallow – a pill that makes tumors glow under infrared light.

​The FDA has authorized, for the first time, a direct-to-consumer (DTC) genetic test to report on three genetic variants found on BRCA1 and BRCA2 genes. These genetic variants are known to increase a person’s risk for developing primarily breast cancer, but also also ovarian or prostate cancers.

An AI system that uses machine learning to predict which high-risk breast lesions are most likely to become cancerous is set to help reduce unnecessary and invasive surgeries.